Marina Udier
Director/Board Member bij CELYAD ONCOLOGY SA
Profiel
Marina Udier is currently the Chief Executive Officer & Director at Nouscom AG since 2020.
She is also the Chief Executive Officer & Director at Nouscom Srl.
Prior to her current positions, Dr. Udier served as an Independent Director at Celyad Oncology SA starting in 2011.
She has former experience as the Head-Global Commercial at Novartis AG and as the Chief Operating Officer at Versant Venture Management LLC.
Dr. Udier holds a doctorate degree from Yale University.
Actieve functies van Marina Udier
Bedrijven | Functie | Begin |
---|---|---|
CELYAD ONCOLOGY SA | Director/Board Member | 11-01-2011 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Chief Executive Officer | 01-05-2019 |
Nouscom Srl | Chief Executive Officer | - |
Eerdere bekende functies van Marina Udier
Bedrijven | Functie | Einde |
---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Chief Operating Officer | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Opleiding van Marina Udier
Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NOVARTIS AG | Health Technology |
CELYAD ONCOLOGY SA | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Nouscom Srl | Commercial Services |